PCM
RGNX icon

Prelude Capital Management’s Regenxbio RGNX Stock Holding History

Prelude Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-82,321
Closed -$676K – 1338
2025
Q2 		$676K Sell
82,321
-30,199
-27% -$253K 0.07% 360
2025
Q1 		$805K Buy
+112,520
New +$837K 0.06% 361
2024
Q2 		– Sell
-21,565
Closed -$454K – 1450
2024
Q1 		$454K Buy
+21,565
New +$384K 0.02% 675
2020
Q4 		– Sell
-2,017
Closed -$56K – 1865
2020
Q3 		$56K Hold
2,017
– – ﹤0.01% 1091
2020
Q2 		$74K Buy
2,017
+2,013
+50,325% +$75K ﹤0.01% 1039
2020
Q1 		$0 Sell
4
-1,462
-100% -$60.9K ﹤0.01% 1935
2019
Q4 		$60K Buy
+1,466
New +$57.9K ﹤0.01% 1278
2019
Q2 		– Sell
-151
Closed -$9K – 2069
2019
Q1 		$9K Buy
+151
New +$7.48K ﹤0.01% 1476
2018
Q4 		– Sell
-200
Closed -$15K – 2103
2018
Q3 		$15K Sell
200
-9,125
-98% -$657K ﹤0.01% 1374
2018
Q2 		$669K Buy
9,325
+965
+12% +$46.1K 0.04% 438
2018
Q1 		$250K Buy
+8,360
New +$243K 0.02% 634
2017
Q4 		– Sell
-6,055
Closed -$200K – 1653
2017
Q3 		$200K Buy
6,055
+416
+7% +$9.36K 0.02% 651
2017
Q2 		$111K Buy
5,639
+3,308
+142% +$64.1K 0.01% 749
2017
Q1 		$45K Buy
+2,331
New +$45K ﹤0.01% 1028

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Prelude Capital Management's RGNX Position: Q3 2025 in Review

Prelude Capital Management sold out of Regenxbio (RGNX) in Q3 2025, closing a stake of 82,321 shares — an estimated $676K sold.

Prelude Capital Management first reported a position in RGNX in Q1 2017 and held it in 14 quarters. The position peaked at $805K in Q1 2025. 166 funds tracked by Wall St. Rank hold RGNX as of Q3 2025.

  • Prelude Capital Management reported no remaining Regenxbio position as of Q3 2025 after selling out during the quarter.
  • Prelude Capital Management sold 82,321 Regenxbio shares in Q3 2025, an estimated $676K.
  • Prelude Capital Management first reported a position in Regenxbio in Q1 2017 and held it in 14 quarters.
  • Prelude Capital Management's Regenxbio position peaked at $805K in Q1 2025.
  • 166 funds tracked by Wall St. Rank held Regenxbio as of Q3 2025.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.